Literature DB >> 12466112

Disease-associated prion protein in vessel walls.

Oskar Koperek1, Gábor G Kovács, Diane Ritchie, James W Ironside, Herbert Budka, Georg Wick.   

Abstract

Human prion diseases like Creutzfeldt-Jakob disease are infectious, inherited, or sporadic neurodegenerative disorders, characterized by the accumulation of an abnormal isoform of the host-encoded prion protein. This affects nervous tissue in sporadic Creutzfeldt-Jakob disease and, additionally, in lymphoid tissue in bovine spongiform encephalopathy-linked variant Creutzfeldt-Jakob disease. Experimental studies have established the involvement of cells of the lymphoid and peripheral nervous system in the transport of prions to their target central nervous system tissue. To evaluate the role of vessel wall-associated mobile cells, we obtained formalin-fixed tissue blocks from various brain regions and/or basal arteries from sporadic, variant and iatrogenic Creutzfeldt-Jakob disease, and unselected control cases. We demonstrate disease-associated prion protein deposits in intracranial vessel walls, in sporadic and variant Creutzfeldt-Jakob disease by performing immunohistochemical staining and paraffin-embedded tissue blotting. Using double immunofluorescence, these deposits co-localize with HLA-DR and S-100 immunoreactive cells in the intima, which are components of the vascular-associated dendritic cell network, as well as with HLA-DR and CD-68 immunopositive macrophages of the intima and media. We conclude that mobile cells in vessel walls like dendritic and monocyte/macrophage lineage cells may be involved in spread of disease-associated prion protein and possibly also of infectivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466112      PMCID: PMC1850927          DOI: 10.1016/S0002-9440(10)64474-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

Review 1.  The role of chemokines in the regulation of dendritic cell trafficking.

Authors:  S Sozzani; P Allavena; A Vecchi; A Mantovani
Journal:  J Leukoc Biol       Date:  1999-07       Impact factor: 4.962

Review 2.  Prions and transfusion medicine.

Authors:  H Budka
Journal:  Vox Sang       Date:  2000       Impact factor: 2.144

3.  Cellular uptake of the prion protein fragment PrP106-126 in vitro.

Authors:  S J McHattie; D R Brown; M M Bird
Journal:  J Neurocytol       Date:  1999-02

4.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

5.  The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases.

Authors:  W J Schulz-Schaeffer; S Tschöke; N Kranefuss; W Dröse; D Hause-Reitner; A Giese; M H Groschup; H A Kretzschmar
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

6.  Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets.

Authors:  J Bieschke; A Giese; W Schulz-Schaeffer; I Zerr; S Poser; M Eigen; H Kretzschmar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

7.  Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice.

Authors:  C Lemaire-Vieille; T Schulze; V Podevin-Dimster; J Follet; Y Bailly; F Blanquet-Grossard; J P Decavel; E Heinen; J Y Cesbron
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 8.  Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease.

Authors:  R O Weller; A Massey; Y M Kuo; A E Roher
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

9.  Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases.

Authors:  M M Esiri; J Carter; J W Ironside
Journal:  Neuropathol Appl Neurobiol       Date:  2000-06       Impact factor: 8.090

Review 10.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  12 in total

Review 1.  In vitro methods in the study of viral and prion permeability across the blood-brain barrier.

Authors:  Ryota Nakaoke; William A Banks
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

2.  Oral scrapie infection modifies the homeostasis of Peyer's patches' dendritic cells.

Authors:  Gauthier Dorban; Valérie Defaweux; Etienne Levavasseur; Caroline Demonceau; Olivier Thellin; Sylvain Flandroy; Joëlle Piret; Nandini Falisse; Ernst Heinen; Nadine Antoine
Journal:  Histochem Cell Biol       Date:  2007-07-11       Impact factor: 4.304

3.  Maternal smoking during pregnancy and cord blood DNA methylation: new insight on sex differences and effect modification by maternal folate levels.

Authors:  Boyang Zhang; Xiumei Hong; Hongkai Ji; Wan-Yee Tang; Mary Kimmel; Yuelong Ji; Colleen Pearson; Barry Zuckerman; Pamela J Surkan; Xiaobin Wang
Journal:  Epigenetics       Date:  2018-07-30       Impact factor: 4.528

4.  Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells.

Authors:  Catherine Rybner-Barnier; Catherine Jacquemot; Céline Cuche; Grégory Doré; Laleh Majlessi; Marie-Madeleine Gabellec; Arnaud Moris; Olivier Schwartz; James Di Santo; Ana Cumano; Claude Leclerc; Françoise Lazarini
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 5.  VEGF: a critical player in neurodegeneration.

Authors:  Erik Storkebaum; Peter Carmeliet
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 6.  Prion diseases: from protein to cell pathology.

Authors:  Gabor G Kovacs; Herbert Budka
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

Review 7.  The Good, the Bad, and the Ugly of Dendritic Cells during Prion Disease.

Authors:  Neil Andrew Mabbott; Barry Matthew Bradford
Journal:  J Immunol Res       Date:  2015-11-30       Impact factor: 4.818

8.  Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.

Authors:  Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; Enrique Alcalde-Cabero; Fernando José García López; Javier Almazán-Isla; María Ruiz-Tovar; Maria-José Medrano; Fuencisla Avellanal; Olga Calero; Miguel Calero
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

9.  Comparative Incidence of Conformational, Neurodegenerative Disorders.

Authors:  Jesús de Pedro-Cuesta; Alberto Rábano; Pablo Martínez-Martín; María Ruiz-Tovar; Enrique Alcalde-Cabero; Javier Almazán-Isla; Fuencisla Avellanal; Miguel Calero
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

Review 10.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.